<?xml version="1.0" encoding="UTF-8"?>
<p>NAD acts at a cellular level and it is still unclear whether oral or intravenous supplementation with NAD donors, such as NR and nicotinic acid, will increase NAD levels and exert a clinical benefit in humans. However, COVID-19 patients may benefit tremendously from these compounds, as SARS-CoV-2-infected patients have increased levels of CD38+, and NAD has been shown to enhance DNA repair via PARP pathways [
 <xref rid="r97" ref-type="bibr">97</xref>].
</p>
